3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
10
Recurrence
4
Neurofibrosarcoma
2
Myeloproliferative Disorders
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myeloid, Acute
2
Endometrial Neoplasms
2
Wilms Tumor
1
Vascular Neoplasms
1
Uterine Neoplasms
1
Uterine Diseases
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rhabdoid Tumor
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Neoplasms by Site
1
Neoplasms
1
Myoepithelioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell
1
Lymphoma
1
Liposarcoma, Myxoid
1
Interventions
glofitamab
2
Cyclophosphamide
2
pembrolizumab
1
obinutuzumab
1
fludarabine phosphate
1
Whole-Body Irradiation
1
Tacrolimus
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Gemcitabine
1
Etoposide
1
Cyclosporine
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Dendritic Cell Sarcoma, Interdigitating
×
selinexor
×
90 days
×
Clear all
No trials found.